Source : 2023 Industry Innovation Strategy Based on Patent Big Data (KIPO- Korean Intellectual Property Office)
In 2025, STRI filed approximately 1,800 additional KH Cells (KH Cells: a new type of pluripotent stem cell that does not form tumors but instead eliminates and suppresses cancer cells, while inducing down-aging effects) -related patents—including PCT applications—in 159 countries such as Korea, the United States, EU, Japan, and Australia and etc. As a result, STRI has registered and applied a total of around 2,000 KHC patents.